In the present study, nanoemulsions maintained a pH between 6.4 and 6.5, consistent with findings reported by Kharat et al
Besides serious adverse events, patients reported nausea, vomiting, abdominal pain, diarrhea, and constipation
The workgroup members all disclosed any conflicts of interest, and all participated in a careful review of the objectives, background, rationale and statistical methods used in this study
Today, the FDA has expanded the benefits of Ozempic to a new patient population that needs critical treatment options to reduce the risk of kidney disease worsening, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults with type 2 diabetes and chronic kidney disease